×

Use of equol for treating androgen mediated diseases

  • US 9,089,547 B2
  • Filed: 05/28/2013
  • Issued: 07/28/2015
  • Est. Priority Date: 10/29/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of modulating physiological and pathophysiological conditions of benign prostatic hyperplasia and prostate cancer and mediated by androgens in a mammal, comprising administering an effective amount of equol comprising a racemic mixture of R-equol and S-equol enantiomers to the mammal thereby modulating physiological and pathophysiological conditions of benign prostatic hyperplasia and prostate cancer and mediated by androgens in the mammal.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×